Washington: Ranbaxy Laboratories "systemically violated" good manufacturing practices, says the whisteblower whose alert led to a US probe, a day after India`s top drugmaker agreed to pay a hefty USD 500 million to settle charges over its adulterated drugs.
Subrata Roy denied parole in Sahara case
Hamas uses donkey to attack Israeli troops
MP: Biker falls into river while crossing bridge
Don`t take us for granted, NCP warns Congress